SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4md8'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1CET_A_CLQA1001_0 (PROTEIN (L-LACTATE DEHYDROGENASE))	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 9	VAL E 293 ASP E 130 ILE E 133 ALA E 297 PHE E 324	None	1.19A	1cetA-4md8E: undetectable	1cetA-4md8E: 20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RU9_H_ACTH611_0 (IMMUNOGLOBULIN IGG2A, HEAVY CHAIN IMMUNOGLOBULIN IGG2A, LIGHT CHAIN)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 6	LEU E 249 TRP E 281 LEU E 301 PHE E 232	None	1.44A	1ru9H-4md8E: undetectable 1ru9L-4md8E: undetectable	1ru9H-4md8E: 19.70 1ru9L-4md8E: 18.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWJ_A_BAXA1723_2 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 7	LYS E 68 LEU E 85 ILE E 94 ILE E 152	None	0.62A	1uwjA-4md8E: 4.8	1uwjA-4md8E: 21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_A_CIOA603_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	HIS E 154 LEU E 85 ILE E 174 MET E 163 PHE E 113	None	1.34A	1xomA-4md8E: undetectable	1xomA-4md8E: 21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOM_B_CIOB601_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	HIS E 154 LEU E 85 ILE E 174 MET E 163 PHE E 113	None	1.33A	1xomB-4md8E: undetectable	1xomB-4md8E: 21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_A_VDNA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	HIS E 154 LEU E 85 ILE E 174 MET E 163 PHE E 113	None	1.39A	1xotA-4md8E: undetectable	1xotA-4md8E: 21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOT_B_VDNB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	HIS E 154 LEU E 85 ILE E 174 MET E 163 PHE E 113	None	1.40A	1xotB-4md8E: undetectable	1xotB-4md8E: 21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOU_A_CQAA403_0 (HISTAMINE N-METHYLTRANSFERASE)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 8	ASP E 14 GLY E 151 ASP E 145 TYR E 12	None	0.92A	2aouA-4md8E: undetectable	2aouA-4md8E: 21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AVD_B_SAMB601_1 (CATECHOL-O-METHYLTRA NSFERASE)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	3 / 3	SER E 7 GLU E 201 ASP E 214	None	0.82A	2avdB-4md8E: undetectable	2avdB-4md8E: 18.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_A_MIXA539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	7 / 12	LEU E 45 GLY E 46 VAL E 53 VAL E 116 ASP E 156 LYS E 158 MET E 163	None	0.85A	2fumA-4md8E: 16.5	2fumA-4md8E: 23.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_A_MIXA539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	8 / 12	LEU E 45 VAL E 53 VAL E 116 ASP E 156 LYS E 158 ASN E 161 MET E 163 ASP E 175	None	0.84A	2fumA-4md8E: 16.5	2fumA-4md8E: 23.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_B_MIXB1539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	7 / 12	LEU E 45 GLY E 46 VAL E 53 VAL E 116 LYS E 158 ASN E 161 MET E 163	None	0.76A	2fumB-4md8E: 16.5	2fumB-4md8E: 23.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_B_MIXB1539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	7 / 12	LEU E 45 VAL E 53 VAL E 116 LYS E 158 ASN E 161 MET E 163 ASP E 175	None	0.79A	2fumB-4md8E: 16.5	2fumB-4md8E: 23.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FUM_D_MIXD3539_1 (PROBABLE SERINE/THREONINE-PRO TEIN KINASE PKNB)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	7 / 12	LEU E 45 GLY E 46 GLY E 48 VAL E 53 LYS E 158 ASN E 161 MET E 163	None	0.86A	2fumD-4md8E: 15.1	2fumD-4md8E: 23.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VAV_F_CSCF1383_2 (ACETYL-COA--DEACETYL CEPHALOSPORIN C ACETYLTRANSFERASE)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	3 / 3	LEU E 213 MET E 153 MET E 137	None	0.66A	2vavF-4md8E: undetectable	2vavF-4md8E: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YJA_B_ESTB1550_1 (ESTROGEN RECEPTOR)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	ALA E 318 GLU E 317 LEU E 313 ARG E 10 GLY E 219	None	1.08A	2yjaB-4md8E: undetectable	2yjaB-4md8E: 19.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3C6G_A_VD3A701_1 (CYTOCHROME P450 2R1)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	LEU E 41 ALA E 56 ALA E 110 GLY E 34 ILE E 59	None	1.07A	3c6gA-4md8E: undetectable	3c6gA-4md8E: 20.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3G4L_B_ROFB902_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	HIS E 154 LEU E 85 ILE E 174 MET E 163 PHE E 113	None	1.32A	3g4lB-4md8E: undetectable	3g4lB-4md8E: 22.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OLS_A_ESTA600_1 (ESTROGEN RECEPTOR BETA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	ALA E 318 GLU E 317 LEU E 313 ARG E 10 GLY E 219	None	1.06A	3olsA-4md8E: undetectable	3olsA-4md8E: 20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UUD_A_ESTA600_1 (ESTROGEN RECEPTOR)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 11	ALA E 318 GLU E 317 LEU E 313 ARG E 10 GLY E 219	None	1.16A	3uudA-4md8E: undetectable	3uudA-4md8E: 19.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3WAR_A_NIOA401_1 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	8 / 8	VAL E 53 VAL E 66 LYS E 68 ILE E 95 PHE E 113 MET E 163 ILE E 174 ASP E 175	None	0.39A	3warA-4md8E: 51.6	3warA-4md8E: 99.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AQL_A_TXCA1452_2 (GUANINE DEAMINASE)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 5	HIS E 148 LEU E 305 LEU E 222 ASP E 302	None	0.97A	4aqlA-4md8E: undetectable	4aqlA-4md8E: 19.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4E7B_C_ACTC513_0 (UDP-N-ACETYLGLUCOSAM INE 1-CARBOXYVINYLTRANSF ERASE)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	3 / 3	TYR E 196 HIS E 234 ARG E 195	None	1.09A	4e7bC-4md8E: undetectable	4e7bC-4md8E: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FUB_A_ACTA311_0 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	3 / 3	TYR E 196 ARG E 244 HIS E 236	None	1.02A	4fubA-4md8E: undetectable	4fubA-4md8E: 19.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LRH_D_FOLD301_1 (FOLATE RECEPTOR ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	3 / 3	HIS E 309 TRP E 216 SER E 7	None	1.21A	4lrhD-4md8E: undetectable	4lrhD-4md8E: 18.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OLT_A_GCSA303_1 (CHITOSANASE)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 6	ILE E 133 ARG E 228 VAL E 285 HIS E 291	None	1.02A	4oltA-4md8E: undetectable	4oltA-4md8E: 20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OLT_B_GCSB303_1 (CHITOSANASE)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 6	ILE E 133 ARG E 228 VAL E 285 HIS E 291	None	0.97A	4oltB-4md8E: undetectable	4oltB-4md8E: 20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PXM_A_ESTA2000_1 (ESTROGEN RECEPTOR)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	ALA E 318 GLU E 317 LEU E 313 ARG E 10 GLY E 219	None	1.12A	4pxmA-4md8E: undetectable	4pxmA-4md8E: 19.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PXM_B_ESTB2000_1 (ESTROGEN RECEPTOR)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 11	ALA E 318 GLU E 317 LEU E 313 ARG E 10 GLY E 219	None	1.13A	4pxmB-4md8E: undetectable	4pxmB-4md8E: 19.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CSH_B_ACTB401_0 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 5	ARG E 80 ARG E 155 LEU E 178 ASN E 189 VAL E 192	None	0.44A	5cshB-4md8E: 50.1	5cshB-4md8E: 93.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CU6_A_ACTA402_0 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 4	ARG E 80 ARG E 155 LEU E 178 ASN E 189	None	0.44A	5cu6A-4md8E: 50.0	5cu6A-4md8E: 98.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CU6_A_ACTA403_0 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 6	TYR E 39 ILE E 69 VAL E 101 ALA E 110	None	0.22A	5cu6A-4md8E: 50.0	5cu6A-4md8E: 98.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CVF_A_ACTA403_0 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 4	ARG E 80 ARG E 155 LEU E 178 ASN E 189	None	0.42A	5cvfA-4md8E: 50.0	5cvfA-4md8E: 98.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DX3_A_ESTA601_1 (ESTROGEN RECEPTOR)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 10	ALA E 318 GLU E 317 LEU E 313 ARG E 10 GLY E 219	None	1.08A	5dx3A-4md8E: undetectable	5dx3A-4md8E: 19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DXB_A_ESTA1000_1 (ESTROGEN RECEPTOR)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 10	ALA E 318 GLU E 317 LEU E 313 ARG E 10 GLY E 219	None	1.08A	5dxbA-4md8E: undetectable	5dxbA-4md8E: 19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DXB_B_ESTB601_1 (ESTROGEN RECEPTOR)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 11	ALA E 318 GLU E 317 LEU E 313 ARG E 10 GLY E 219	None	1.12A	5dxbB-4md8E: undetectable	5dxbB-4md8E: 19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DXG_B_ESTB601_1 (ESTROGEN RECEPTOR)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 11	ALA E 318 GLU E 317 LEU E 313 ARG E 10 GLY E 219	None	1.13A	5dxgB-4md8E: undetectable	5dxgB-4md8E: 19.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GTR_A_ESTA601_1 (ESTROGEN RECEPTOR)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	ALA E 318 GLU E 317 LEU E 313 ARG E 10 GLY E 219	None	1.10A	5gtrA-4md8E: undetectable	5gtrA-4md8E: 19.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OS7_A_ACTA401_0 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 4	ARG E 80 ARG E 155 LEU E 178 ASN E 189	None	0.43A	5os7A-4md8E: 43.4	5os7A-4md8E: 93.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OS7_A_ACTA402_0 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	3 / 3	HIS E 276 SER E 277 LYS E 279	None	0.32A	5os7A-4md8E: 43.4	5os7A-4md8E: 93.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OS7_A_ACTA403_0 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 4	ARG E 195 TYR E 196 HIS E 234 HIS E 236	None	0.46A	5os7A-4md8E: 43.4	5os7A-4md8E: 93.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OS7_B_ACTB401_0 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 5	ARG E 80 ARG E 155 LEU E 178 ASN E 189 VAL E 192	None	0.43A	5os7B-4md8E: 50.6	5os7B-4md8E: 93.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OS8_A_ACTA402_0 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 5	LYS E 77 ARG E 80 ARG E 155 LEU E 178 ASN E 189	None	0.48A	5os8A-4md8E: 50.2	5os8A-4md8E: 98.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OSP_A_ACTA402_0 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 4	ARG E 80 ARG E 155 LEU E 178 ASN E 189	None	0.45A	5ospA-4md8E: 50.4	5ospA-4md8E: 94.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OSR_A_ACTA401_0 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 5	ARG E 80 ARG E 155 LEU E 178 ASN E 189	None	0.45A	5osrA-4md8E: 49.7	5osrA-4md8E: 94.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OSR_A_ACTA402_0 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 7	TYR E 39 VAL E 67 ILE E 69 VAL E 101 ALA E 110	None	0.16A	5osrA-4md8E: 49.7	5osrA-4md8E: 94.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5OTR_A_ACTA401_0 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 5	ARG E 80 ARG E 155 LEU E 178 ASN E 189	None	0.44A	5otrA-4md8E: 49.3	5otrA-4md8E: 94.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VLM_G_CVIG301_1 (REGULATORY PROTEIN TETR)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 7	GLY E 185 TYR E 257 ASP E 210 TYR E 211	None	1.20A	5vlmG-4md8E: undetectable	5vlmG-4md8E: 18.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WGQ_A_ESTA601_1 (ESTROGEN RECEPTOR)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 9	ALA E 318 GLU E 317 LEU E 313 ARG E 10 GLY E 219	None	1.14A	5wgqA-4md8E: undetectable	5wgqA-4md8E: 14.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5Y9M_X_NIOX401_1 (CASEIN KINASE II SUBUNIT ALPHA')	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	7 / 8	VAL E 53 VAL E 66 LYS E 68 PHE E 113 MET E 163 ILE E 174 ASP E 175	None	0.48A	5y9mX-4md8E: 42.5	5y9mX-4md8E: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5YF9_B_NIOB401_1 (CASEIN KINASE II SUBUNIT ALPHA')	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	7 / 7	VAL E 53 VAL E 66 LYS E 68 PHE E 113 MET E 163 ILE E 174 ASP E 175	None	0.57A	5yf9B-4md8E: 36.7	5yf9B-4md8E: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5YF9_X_NIOX401_1 (CASEIN KINASE II SUBUNIT ALPHA')	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 9	LEU E 45 VAL E 53 VAL E 66 PHE E 113 ASP E 175	None	0.68A	5yf9X-4md8E: 29.6	5yf9X-4md8E: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5YF9_X_NIOX401_1 (CASEIN KINASE II SUBUNIT ALPHA')	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	8 / 9	VAL E 53 VAL E 66 LYS E 68 ILE E 95 PHE E 113 MET E 163 ILE E 174 ASP E 175	None	0.54A	5yf9X-4md8E: 29.6	5yf9X-4md8E: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5YF9_X_NIOX401_1 (CASEIN KINASE II SUBUNIT ALPHA')	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 9	VAL E 53 VAL E 66 LYS E 68 ILE E 174 PHE E 113	None	1.24A	5yf9X-4md8E: 29.6	5yf9X-4md8E: 77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5YWM_X_NIOX403_0 (CASEIN KINASE II SUBUNIT ALPHA')	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	7 / 7	VAL E 53 VAL E 66 LYS E 68 ILE E 95 PHE E 113 ILE E 174 ASP E 175	None	0.43A	5ywmX-4md8E: 47.0	5ywmX-4md8E: 77.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_B_TA1B501_1 (TUBULIN BETA CHAIN)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	ASP E 25 GLU E 22 LEU E 111 LEU E 70 LEU E 97	None	1.03A	6ew0B-4md8E: undetectable	6ew0B-4md8E: 11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_D_TA1D501_1 (TUBULIN BETA CHAIN)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	ASP E 25 GLU E 22 LEU E 111 LEU E 70 LEU E 97	None	1.04A	6ew0D-4md8E: undetectable	6ew0D-4md8E: 11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_H_TA1H501_1 (TUBULIN BETA CHAIN)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	ASP E 25 GLU E 22 LEU E 111 LEU E 70 LEU E 97	None	1.03A	6ew0H-4md8E: undetectable	6ew0H-4md8E: 11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EW0_I_TA1I501_1 (TUBULIN BETA CHAIN)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 12	ASP E 25 GLU E 22 LEU E 111 LEU E 70 LEU E 97	None	1.04A	6ew0I-4md8E: undetectable	6ew0I-4md8E: 11.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6GMD_A_ACTA401_0 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	5 / 5	ARG E 80 ARG E 155 LEU E 178 ASN E 189 VAL E 192	None	0.43A	6gmdA-4md8E: 50.5	6gmdA-4md8E: 93.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6GMD_B_ACTB401_0 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 4	ARG E 80 ARG E 155 LEU E 178 ASN E 189	None	0.43A	6gmdB-4md8E: 43.4	6gmdB-4md8E: 93.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6GMD_B_ACTB402_0 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	3 / 3	HIS E 276 SER E 277 LYS E 279	None	0.32A	6gmdB-4md8E: 43.4	6gmdB-4md8E: 93.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6GMD_B_ACTB403_0 (CASEIN KINASE II SUBUNIT ALPHA)	4md8	CASEIN KINASE II SUBUNIT ALPHA (Homo sapiens)	4 / 4	ARG E 195 TYR E 196 HIS E 234 HIS E 236	None	0.46A	6gmdB-4md8E: 43.4	6gmdB-4md8E: 93.43

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1CET_A_CLQA1001_0","PROTEIN (L-LACTATE DEHYDROGENASE)","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"VAL E 293;ASP E 130;ILE E 133;ALA E 297;PHE E 324","None","1.19A","1cetA-4md8E:undetectable","1cetA-4md8E:20.95"],["1RU9_H_ACTH611_0","IMMUNOGLOBULIN IGG2A, HEAVY CHAIN;IMMUNOGLOBULIN IGG2A, LIGHT CHAIN","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"LEU E 249;TRP E 281;LEU E 301;PHE E 232","None","1.44A","1ru9H-4md8E:undetectable;1ru9L-4md8E:undetectable","1ru9H-4md8E:19.70;1ru9L-4md8E:18.88"],["1UWJ_A_BAXA1723_2","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"LYS E  68;LEU E  85;ILE E  94;ILE E 152","None","0.62A","1uwjA-4md8E:4.8","1uwjA-4md8E:21.43"],["1XOM_A_CIOA603_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"HIS E 154;LEU E  85;ILE E 174;MET E 163;PHE E 113","None","1.34A","1xomA-4md8E:undetectable","1xomA-4md8E:21.35"],["1XOM_B_CIOB601_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"HIS E 154;LEU E  85;ILE E 174;MET E 163;PHE E 113","None","1.33A","1xomB-4md8E:undetectable","1xomB-4md8E:21.35"],["1XOT_A_VDNA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"HIS E 154;LEU E  85;ILE E 174;MET E 163;PHE E 113","None","1.39A","1xotA-4md8E:undetectable","1xotA-4md8E:21.72"],["1XOT_B_VDNB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"HIS E 154;LEU E  85;ILE E 174;MET E 163;PHE E 113","None","1.40A","1xotB-4md8E:undetectable","1xotB-4md8E:21.72"],["2AOU_A_CQAA403_0","HISTAMINE N-METHYLTRANSFERASE","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ASP E  14;GLY E 151;ASP E 145;TYR E  12","None","0.92A","2aouA-4md8E:undetectable","2aouA-4md8E:21.12"],["2AVD_B_SAMB601_1","CATECHOL-O-METHYLTRANSFERASE","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",3,"SER E   7;GLU E 201;ASP E 214","None","0.82A","2avdB-4md8E:undetectable","2avdB-4md8E:18.97"],["2FUM_A_MIXA539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",7,"LEU E  45;GLY E  46;VAL E  53;VAL E 116;ASP E 156;LYS E 158;MET E 163","None","0.85A","2fumA-4md8E:16.5","2fumA-4md8E:23.50"],["2FUM_A_MIXA539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",8,"LEU E  45;VAL E  53;VAL E 116;ASP E 156;LYS E 158;ASN E 161;MET E 163;ASP E 175","None","0.84A","2fumA-4md8E:16.5","2fumA-4md8E:23.50"],["2FUM_B_MIXB1539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",7,"LEU E  45;GLY E  46;VAL E  53;VAL E 116;LYS E 158;ASN E 161;MET E 163","None","0.76A","2fumB-4md8E:16.5","2fumB-4md8E:23.50"],["2FUM_B_MIXB1539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",7,"LEU E  45;VAL E  53;VAL E 116;LYS E 158;ASN E 161;MET E 163;ASP E 175","None","0.79A","2fumB-4md8E:16.5","2fumB-4md8E:23.50"],["2FUM_D_MIXD3539_1","PROBABLE SERINE\/THREONINE-PROTEIN KINASE PKNB","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",7,"LEU E  45;GLY E  46;GLY E  48;VAL E  53;LYS E 158;ASN E 161;MET E 163","None","0.86A","2fumD-4md8E:15.1","2fumD-4md8E:23.50"],["2VAV_F_CSCF1383_2","ACETYL-COA--DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",3,"LEU E 213;MET E 153;MET E 137","None","0.66A","2vavF-4md8E:undetectable","2vavF-4md8E:20.70"],["2YJA_B_ESTB1550_1","ESTROGEN RECEPTOR","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ALA E 318;GLU E 317;LEU E 313;ARG E  10;GLY E 219","None","1.08A","2yjaB-4md8E:undetectable","2yjaB-4md8E:19.20"],["3C6G_A_VD3A701_1","CYTOCHROME P450 2R1","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"LEU E  41;ALA E  56;ALA E 110;GLY E  34;ILE E  59","None","1.07A","3c6gA-4md8E:undetectable","3c6gA-4md8E:20.52"],["3G4L_B_ROFB902_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"HIS E 154;LEU E  85;ILE E 174;MET E 163;PHE E 113","None","1.32A","3g4lB-4md8E:undetectable","3g4lB-4md8E:22.38"],["3OLS_A_ESTA600_1","ESTROGEN RECEPTOR BETA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ALA E 318;GLU E 317;LEU E 313;ARG E  10;GLY E 219","None","1.06A","3olsA-4md8E:undetectable","3olsA-4md8E:20.22"],["3UUD_A_ESTA600_1","ESTROGEN RECEPTOR","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ALA E 318;GLU E 317;LEU E 313;ARG E  10;GLY E 219","None","1.16A","3uudA-4md8E:undetectable","3uudA-4md8E:19.25"],["3WAR_A_NIOA401_1","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",8,"VAL E  53;VAL E  66;LYS E  68;ILE E  95;PHE E 113;MET E 163;ILE E 174;ASP E 175","None","0.39A","3warA-4md8E:51.6","3warA-4md8E:99.70"],["4AQL_A_TXCA1452_2","GUANINE DEAMINASE","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"HIS E 148;LEU E 305;LEU E 222;ASP E 302","None","0.97A","4aqlA-4md8E:undetectable","4aqlA-4md8E:19.50"],["4E7B_C_ACTC513_0","UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",3,"TYR E 196;HIS E 234;ARG E 195","None","1.09A","4e7bC-4md8E:undetectable","4e7bC-4md8E:21.48"],["4FUB_A_ACTA311_0","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",3,"TYR E 196;ARG E 244;HIS E 236","None","1.02A","4fubA-4md8E:undetectable","4fubA-4md8E:19.44"],["4LRH_D_FOLD301_1","FOLATE RECEPTOR ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",3,"HIS E 309;TRP E 216;SER E   7","None","1.21A","4lrhD-4md8E:undetectable","4lrhD-4md8E:18.56"],["4OLT_A_GCSA303_1","CHITOSANASE","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ILE E 133;ARG E 228;VAL E 285;HIS E 291","None","1.02A","4oltA-4md8E:undetectable","4oltA-4md8E:20.62"],["4OLT_B_GCSB303_1","CHITOSANASE","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ILE E 133;ARG E 228;VAL E 285;HIS E 291","None","0.97A","4oltB-4md8E:undetectable","4oltB-4md8E:20.62"],["4PXM_A_ESTA2000_1","ESTROGEN RECEPTOR","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ALA E 318;GLU E 317;LEU E 313;ARG E  10;GLY E 219","None","1.12A","4pxmA-4md8E:undetectable","4pxmA-4md8E:19.30"],["4PXM_B_ESTB2000_1","ESTROGEN RECEPTOR","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ALA E 318;GLU E 317;LEU E 313;ARG E  10;GLY E 219","None","1.13A","4pxmB-4md8E:undetectable","4pxmB-4md8E:19.30"],["5CSH_B_ACTB401_0","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ARG E  80;ARG E 155;LEU E 178;ASN E 189;VAL E 192","None","0.44A","5cshB-4md8E:50.1","5cshB-4md8E:93.43"],["5CU6_A_ACTA402_0","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ARG E  80;ARG E 155;LEU E 178;ASN E 189","None","0.44A","5cu6A-4md8E:50.0","5cu6A-4md8E:98.48"],["5CU6_A_ACTA403_0","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"TYR E  39;ILE E  69;VAL E 101;ALA E 110","None","0.22A","5cu6A-4md8E:50.0","5cu6A-4md8E:98.48"],["5CVF_A_ACTA403_0","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ARG E  80;ARG E 155;LEU E 178;ASN E 189","None","0.42A","5cvfA-4md8E:50.0","5cvfA-4md8E:98.48"],["5DX3_A_ESTA601_1","ESTROGEN RECEPTOR","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ALA E 318;GLU E 317;LEU E 313;ARG E  10;GLY E 219","None","1.08A","5dx3A-4md8E:undetectable","5dx3A-4md8E:19.80"],["5DXB_A_ESTA1000_1","ESTROGEN RECEPTOR","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ALA E 318;GLU E 317;LEU E 313;ARG E  10;GLY E 219","None","1.08A","5dxbA-4md8E:undetectable","5dxbA-4md8E:19.80"],["5DXB_B_ESTB601_1","ESTROGEN RECEPTOR","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ALA E 318;GLU E 317;LEU E 313;ARG E  10;GLY E 219","None","1.12A","5dxbB-4md8E:undetectable","5dxbB-4md8E:19.80"],["5DXG_B_ESTB601_1","ESTROGEN RECEPTOR","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ALA E 318;GLU E 317;LEU E 313;ARG E  10;GLY E 219","None","1.13A","5dxgB-4md8E:undetectable","5dxgB-4md8E:19.80"],["5GTR_A_ESTA601_1","ESTROGEN RECEPTOR","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ALA E 318;GLU E 317;LEU E 313;ARG E  10;GLY E 219","None","1.10A","5gtrA-4md8E:undetectable","5gtrA-4md8E:19.49"],["5OS7_A_ACTA401_0","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ARG E  80;ARG E 155;LEU E 178;ASN E 189","None","0.43A","5os7A-4md8E:43.4","5os7A-4md8E:93.43"],["5OS7_A_ACTA402_0","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",3,"HIS E 276;SER E 277;LYS E 279","None","0.32A","5os7A-4md8E:43.4","5os7A-4md8E:93.43"],["5OS7_A_ACTA403_0","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ARG E 195;TYR E 196;HIS E 234;HIS E 236","None","0.46A","5os7A-4md8E:43.4","5os7A-4md8E:93.43"],["5OS7_B_ACTB401_0","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ARG E  80;ARG E 155;LEU E 178;ASN E 189;VAL E 192","None","0.43A","5os7B-4md8E:50.6","5os7B-4md8E:93.43"],["5OS8_A_ACTA402_0","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"LYS E  77;ARG E  80;ARG E 155;LEU E 178;ASN E 189","None","0.48A","5os8A-4md8E:50.2","5os8A-4md8E:98.48"],["5OSP_A_ACTA402_0","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ARG E  80;ARG E 155;LEU E 178;ASN E 189","None","0.45A","5ospA-4md8E:50.4","5ospA-4md8E:94.80"],["5OSR_A_ACTA401_0","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ARG E  80;ARG E 155;LEU E 178;ASN E 189","None","0.45A","5osrA-4md8E:49.7","5osrA-4md8E:94.80"],["5OSR_A_ACTA402_0","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"TYR E  39;VAL E  67;ILE E  69;VAL E 101;ALA E 110","None","0.16A","5osrA-4md8E:49.7","5osrA-4md8E:94.80"],["5OTR_A_ACTA401_0","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ARG E  80;ARG E 155;LEU E 178;ASN E 189","None","0.44A","5otrA-4md8E:49.3","5otrA-4md8E:94.80"],["5VLM_G_CVIG301_1","REGULATORY PROTEIN TETR","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"GLY E 185;TYR E 257;ASP E 210;TYR E 211","None","1.20A","5vlmG-4md8E:undetectable","5vlmG-4md8E:18.25"],["5WGQ_A_ESTA601_1","ESTROGEN RECEPTOR","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ALA E 318;GLU E 317;LEU E 313;ARG E  10;GLY E 219","None","1.14A","5wgqA-4md8E:undetectable","5wgqA-4md8E:14.02"],["5Y9M_X_NIOX401_1","CASEIN KINASE II SUBUNIT ALPHA'","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",7,"VAL E  53;VAL E  66;LYS E  68;PHE E 113;MET E 163;ILE E 174;ASP E 175","None","0.48A","5y9mX-4md8E:42.5","5y9mX-4md8E:77.50"],["5YF9_B_NIOB401_1","CASEIN KINASE II SUBUNIT ALPHA'","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",7,"VAL E  53;VAL E  66;LYS E  68;PHE E 113;MET E 163;ILE E 174;ASP E 175","None","0.57A","5yf9B-4md8E:36.7","5yf9B-4md8E:77.50"],["5YF9_X_NIOX401_1","CASEIN KINASE II SUBUNIT ALPHA'","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"LEU E  45;VAL E  53;VAL E  66;PHE E 113;ASP E 175","None","0.68A","5yf9X-4md8E:29.6","5yf9X-4md8E:77.50"],["5YF9_X_NIOX401_1","CASEIN KINASE II SUBUNIT ALPHA'","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",8,"VAL E  53;VAL E  66;LYS E  68;ILE E  95;PHE E 113;MET E 163;ILE E 174;ASP E 175","None","0.54A","5yf9X-4md8E:29.6","5yf9X-4md8E:77.50"],["5YF9_X_NIOX401_1","CASEIN KINASE II SUBUNIT ALPHA'","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"VAL E  53;VAL E  66;LYS E  68;ILE E 174;PHE E 113","None","1.24A","5yf9X-4md8E:29.6","5yf9X-4md8E:77.50"],["5YWM_X_NIOX403_0","CASEIN KINASE II SUBUNIT ALPHA'","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",7,"VAL E  53;VAL E  66;LYS E  68;ILE E  95;PHE E 113;ILE E 174;ASP E 175","None","0.43A","5ywmX-4md8E:47.0","5ywmX-4md8E:77.50"],["6EW0_B_TA1B501_1","TUBULIN BETA CHAIN","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ASP E  25;GLU E  22;LEU E 111;LEU E  70;LEU E  97","None","1.03A","6ew0B-4md8E:undetectable","6ew0B-4md8E:11.48"],["6EW0_D_TA1D501_1","TUBULIN BETA CHAIN","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ASP E  25;GLU E  22;LEU E 111;LEU E  70;LEU E  97","None","1.04A","6ew0D-4md8E:undetectable","6ew0D-4md8E:11.48"],["6EW0_H_TA1H501_1","TUBULIN BETA CHAIN","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ASP E  25;GLU E  22;LEU E 111;LEU E  70;LEU E  97","None","1.03A","6ew0H-4md8E:undetectable","6ew0H-4md8E:11.48"],["6EW0_I_TA1I501_1","TUBULIN BETA CHAIN","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ASP E  25;GLU E  22;LEU E 111;LEU E  70;LEU E  97","None","1.04A","6ew0I-4md8E:undetectable","6ew0I-4md8E:11.48"],["6GMD_A_ACTA401_0","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",5,"ARG E  80;ARG E 155;LEU E 178;ASN E 189;VAL E 192","None","0.43A","6gmdA-4md8E:50.5","6gmdA-4md8E:93.43"],["6GMD_B_ACTB401_0","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ARG E  80;ARG E 155;LEU E 178;ASN E 189","None","0.43A","6gmdB-4md8E:43.4","6gmdB-4md8E:93.43"],["6GMD_B_ACTB402_0","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",3,"HIS E 276;SER E 277;LYS E 279","None","0.32A","6gmdB-4md8E:43.4","6gmdB-4md8E:93.43"],["6GMD_B_ACTB403_0","CASEIN KINASE II SUBUNIT ALPHA","4md8","CASEIN KINASE II SUBUNIT ALPHA","Homo sapiens",4,"ARG E 195;TYR E 196;HIS E 234;HIS E 236","None","0.46A","6gmdB-4md8E:43.4","6gmdB-4md8E:93.43"]]